BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36437828)

  • 1. Therapeutic and Neuroprotective Effects of Bushen Jianpi Decoction on a Rotenone-Induced Rat Model of Parkinson's Disease.
    Liang W; Yao L; Chen J; Chen Z; Wu X; Huang X
    Evid Based Complement Alternat Med; 2022; 2022():9191284. PubMed ID: 36437828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-asarone and levodopa coadministration increases striatal levels of dopamine and levodopa and improves behavioral competence in Parkinson's rat by enhancing dopa decarboxylase activity.
    Huang L; Deng M; Zhang S; Lu S; Gui X; Fang Y
    Biomed Pharmacother; 2017 Oct; 94():666-678. PubMed ID: 28787702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coadministration of β-asarone and levodopa increases dopamine in rat brain by accelerating transformation of levodopa: a different mechanism from Madopar.
    Huang L; Deng M; Zhang S; Fang Y; Li L
    Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):685-90. PubMed ID: 24910244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease.
    Yue X; Hariri DJ; Caballero B; Zhang S; Bartlett MJ; Kaut O; Mount DW; Wüllner U; Sherman SJ; Falk T
    Neuroscience; 2014 Jan; 258():385-400. PubMed ID: 24291725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective role of apigenin on rotenone induced rat model of Parkinson's disease: Suppression of neuroinflammation and oxidative stress mediated apoptosis.
    Anusha C; Sumathi T; Joseph LD
    Chem Biol Interact; 2017 May; 269():67-79. PubMed ID: 28389404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effects of indole-3-carbinol on the rotenone rat model of Parkinson's disease: Impact of the SIRT1-AMPK signaling pathway.
    Mohamad KA; El-Naga RN; Wahdan SA
    Toxicol Appl Pharmacol; 2022 Jan; 435():115853. PubMed ID: 34973289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanostructure lipid carriers enhance alpha-mangostin neuroprotective efficacy in mice with rotenone-induced neurodegeneration.
    Sakamula R; Yata T; Thong-Asa W
    Metab Brain Dis; 2022 Jun; 37(5):1465-1476. PubMed ID: 35353275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Right vagus nerve stimulation improves motor behavior by exerting neuroprotective effects in Parkinson's disease rats.
    Wang C; Su T; Xiao L; Wang Y; Huo X; Li W; Ding J; Sun T
    Ann Transl Med; 2022 Dec; 10(24):1314. PubMed ID: 36660708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential neuroprotective effect of androst-5-ene-3β, 17β-diol (ADIOL) on the striatum, and substantia nigra in Parkinson's disease rat model.
    Salama RM; Tadros MG; Schaalan MF; Bahaa N; Abdel-Tawab AM; Khalifa AE
    J Cell Physiol; 2018 Aug; 233(8):5981-6000. PubMed ID: 29266208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methyl jasmonate ameliorates rotenone-induced motor deficits in rats through its neuroprotective activity and increased expression of tyrosine hydroxylase immunopositive cells.
    Alabi AO; Ajayi AM; Ben-Azu B; Omorobge O; Umukoro S
    Metab Brain Dis; 2019 Dec; 34(6):1723-1736. PubMed ID: 31463866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of alpha mangostin on rotenone induced toxicity in rat model of Parkinson's disease.
    Parkhe A; Parekh P; Nalla LV; Sharma N; Sharma M; Gadepalli A; Kate A; Khairnar A
    Neurosci Lett; 2020 Jan; 716():134652. PubMed ID: 31778768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects of stemazole in the MPTP-induced acute model of Parkinson's disease: Involvement of the dopamine system.
    Guo Z; Xu S; Du N; Liu J; Huang Y; Han M
    Neurosci Lett; 2016 Mar; 616():152-9. PubMed ID: 26827716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-related biphasic effect of the Parkinson's disease neurotoxin MPTP, on the spread, accumulation, and toxicity of α-synuclein.
    Merghani MM; Ardah MT; Al Shamsi M; Kitada T; Haque ME
    Neurotoxicology; 2021 May; 84():41-52. PubMed ID: 33549656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoamine Oxidase-B Inhibition Facilitates α-Synuclein Secretion
    Nakamura Y; Arawaka S; Sato H; Sasaki A; Shigekiyo T; Takahata K; Tsunekawa H; Kato T
    J Neurosci; 2021 Sep; 41(35):7479-7491. PubMed ID: 34290084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Network Pharmacology-Based Study on the Mechanism of Bushen-Jianpi Decoction in Liver Cancer Treatment.
    Wu R; Li XY; Wang WH; Cai FF; Chen XL; Yang MD; Pan QS; Chen QL; Zhou RY; Su SB
    Evid Based Complement Alternat Med; 2019; 2019():3242989. PubMed ID: 31015849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of caloric vestibular stimulation in improvement of motor symptoms and inhibition of neuronal degeneration in rotenone model of Parkinson's disease - An experimental study.
    Thanalakshmi J; Archana R; Senthilkumar S; Shakila R; Pazhanivel N; Subhashini S
    Physiol Int; 2020 Oct; 107(3):390-405. PubMed ID: 33021954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy: The PD MED Randomized Clinical Trial.
    Gray R; Patel S; Ives N; Rick C; Woolley R; Muzerengi S; Gray A; Jenkinson C; McIntosh E; Wheatley K; Williams A; Clarke CE;
    JAMA Neurol; 2022 Feb; 79(2):131-140. PubMed ID: 34962574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Empagliflozin attenuates neurodegeneration through antioxidant, anti-inflammatory, and modulation of α-synuclein and Parkin levels in rotenone-induced Parkinson's disease in rats.
    Ahmed S; El-Sayed MM; Kandeil MA; Khalaf MM
    Saudi Pharm J; 2022 Jun; 30(6):863-873. PubMed ID: 35812142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sitagliptin and Liraglutide Modulate L-dopa Effect and Attenuate Dyskinetic Movements in Rotenone-Lesioned Rats.
    Badawi GA; Abd El Fattah MA; Zaki HF; El Sayed MI
    Neurotox Res; 2019 Apr; 35(3):635-653. PubMed ID: 30673988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neural-Induced Human Adipose Tissue-Derived Stem Cells Conditioned Medium Ameliorates Rotenone-Induced Toxicity in SH-SY5Y Cells.
    Ramalingam M; Jang S; Jeong HS
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.